Qin X - Search Results

1

Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer.

Qin X, Yang T, Xu H, Zhang R, Zhao S, Kong L, Yang C, Zhang Z. Qin X, et al. J Control Release. 2023 Jul;359:359-372. doi: 10.1016/j.jconrel.2023.05.044. Epub 2023 Jun 14. J Control Release. 2023. PMID: 37290722

2

Biomimetic Nanovesicles for Enhanced Antitumor Activity of Combinational Photothermal and Chemotherapy.

Wu T, Zhang D, Qiao Q, Qin X, Yang C, Kong M, Deng H, Zhang Z. Wu T, et al. Among authors: qin x. Mol Pharm. 2018 Mar 5;15(3):1341-1352. doi: 10.1021/acs.molpharmaceut.7b01142. Epub 2018 Feb 9. Mol Pharm. 2018. PMID: 29397741

3

Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.

Qi Y, Qin X, Yang C, Wu T, Qiao Q, Song Q, Zhang Z. Qi Y, et al. Among authors: qin x. Mol Pharm. 2018 Mar 5;15(3):1005-1016. doi: 10.1021/acs.molpharmaceut.7b00922. Epub 2018 Feb 9. Mol Pharm. 2018. PMID: 29397749

4

A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery.

Yang C, Wu T, Qin Y, Qi Y, Sun Y, Kong M, Jiang X, Qin X, Shen Y, Zhang Z. Yang C, et al. Among authors: qin y, qin x. Int J Nanomedicine. 2018 Mar 6;13:1281-1293. doi: 10.2147/IJN.S154361. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29563787 Free PMC article.

5

Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy.

Hu X, Wu T, Qin X, Qi Y, Qiao Q, Yang C, Zhang Z. Hu X, et al. Among authors: qin x. Adv Healthc Mater. 2019 Jan;8(1):e1800837. doi: 10.1002/adhm.201800837. Epub 2018 Dec 3. Adv Healthc Mater. 2019. PMID: 30506847

6

Extracellular vesicles based self-grown gold nanopopcorn for combinatorial chemo-photothermal therapy.

Zhang D, Qin X, Wu T, Qiao Q, Song Q, Zhang Z. Zhang D, et al. Among authors: qin x. Biomaterials. 2019 Mar;197:220-228. doi: 10.1016/j.biomaterials.2019.01.024. Epub 2019 Jan 14. Biomaterials. 2019. PMID: 30669014

7

Immunostimulatory cytokine and doxorubicin co-loaded nanovesicles for cancer immunochemotherapy.

Wu T, Qiao Q, Qin X, Zhang D, Zhang Z. Wu T, et al. Among authors: qin x. Nanomedicine. 2019 Jun;18:66-77. doi: 10.1016/j.nano.2019.02.008. Epub 2019 Mar 2. Nanomedicine. 2019. PMID: 30831276

8

Intracellularly Generated Immunological Gold Nanoparticles for Combinatorial Photothermal Therapy and Immunotherapy against Tumor.

Zhang D, Wu T, Qin X, Qiao Q, Shang L, Song Q, Yang C, Zhang Z. Zhang D, et al. Among authors: qin x. Nano Lett. 2019 Sep 11;19(9):6635-6646. doi: 10.1021/acs.nanolett.9b02903. Epub 2019 Aug 12. Nano Lett. 2019. PMID: 31393134

9

Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy.

Tu J, Tu K, Xu H, Wang L, Yuan X, Qin X, Kong L, Chu Q, Zhang Z. Tu J, et al. Among authors: qin x. Eur J Pharm Biopharm. 2020 May;150:96-107. doi: 10.1016/j.ejpb.2020.03.003. Epub 2020 Mar 6. Eur J Pharm Biopharm. 2020. PMID: 32151726

10

Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy.

Hu M, Zhang J, Kong L, Yu Y, Hu Q, Yang T, Wang Y, Tu K, Qiao Q, Qin X, Zhang Z. Hu M, et al. Among authors: qin x. ACS Nano. 2021 Feb 23;15(2):3123-3138. doi: 10.1021/acsnano.0c09681. Epub 2021 Jan 20. ACS Nano. 2021. PMID: 33470095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,793 results

Search Page

Filters